Companies:
49,829
Total Market Cap:
139401349447714.90
Global Rank
#21703
Country Rank
#59
Market Cap
157.31 M
Price
0.933
Change (%)
1.37%
Volume
275,511
Lavipharm S.A.'s latest marketcap:
157.31 M
As of 07/05/2025, Lavipharm S.A.'s market capitalization has reached $157.31 M. According to our data, Lavipharm S.A. is the 21703th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 157.31 M |
| Revenue (ttm) | 62.34 M |
| Net Income (ttm) | 10.58 M |
| Shares Out | 168.69 M |
| EPS (ttm) | 0.06 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/17/2025 |
Market Cap Chart
Data Updated: 07/05/2025
Lavipharm S.A.'s yearly market capitalization.
Lavipharm S.A. has seen its market value grow from €7 M to €157.31 M since 2014, representing a total increase of 2,147.95% and an annual compound growth rate (CAGR) of 34.46%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | €157.31 M | 1.01% | 21703 |
| 12/31/2024 | €134.11 M | 0.36% | 21216 |
| 12/29/2023 | €133.62 M | 107.29% | 20658 |
| 12/30/2022 | €64.46 M | 117.58% | 24687 |
| 12/31/2021 | €29.63 M | 23.4% | 29970 |
| 12/31/2020 | €24.01 M | 113.64% | 27656 |
| 12/31/2019 | €11.24 M | 57.14% | 28134 |
| 12/31/2018 | €7.15 M | -14.63% | 28464 |
| 12/29/2017 | €8.38 M | 90.7% | 27615 |
| 12/30/2016 | €4.39 M | -38.57% | 26973 |
Company Profile
About Lavipharm S.A.
Lavipharm S.A. is a leading pharmaceutical company specializing in the research, development, manufacturing, and distribution of healthcare products. Established in 1911, the company is headquartered in Paiania, Greece, and serves both domestic and international markets.
Core Business Activities
- Research and development of pharmaceutical and dermocosmetic products
- Manufacturing, import, and wholesale distribution
- Marketing and sales to physicians and pharmacists
Product Portfolio
Lavipharm offers a diverse range of healthcare solutions, including:
- Pharmaceutical products for cardiology, oncology-urology, central nervous system, and chronic pain management
- Self-treatment solutions
- Prescription medicines and over-the-counter (OTC) products
- LIFELAB CBD line of products
Frequently Asked Questions
-
What is Lavipharm S.A.'s (ATH-LAVI) current market cap?As of 07/05/2025, Lavipharm S.A. (including the parent company, if applicable) has an estimated market capitalization of $157.31 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Lavipharm S.A. (ATH-LAVI) rank globally by market cap?Lavipharm S.A. global market capitalization ranking is approximately 21703 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.